Germany’s Boehringer Ingelheim has bought the Swiss biotech AMAL Therapeutics, a privately-held Swiss biotech focused on immunotherapy and vaccines in oncology.
Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved